Table 2.
Baseline characteristics of trial participants (N = 163), mean ± SD or No. (%)
| Age, y | 52.1 ± 11.4 |
| Women | 85 (52) |
| Race | |
| Non-Hispanic White | 66 (40) |
| Non-Hispanic Black | 82 (50) |
| Hispanic | 11 (7) |
| Asian | 4 (2) |
| Body mass index, kg/m2 | 32.3 ± 5.5 |
| Body mass index | |
| 25–29.9 | 71 (44) |
| ≥ 30 | 92 (56) |
| Waist circumference, cm | 104.4 ± 13.5 |
| Fasting glucose, mg/dL | 97.3 ± 13.6 |
| Fasting insulin, μU/mL | 7.7 ± 5.8 |
| Homeostasis model assessment (HOMA), units | 1.9 ± 1.6 |
| Triglycerides, mg/dL | 104.6 ± 67.1 |
| HDL cholesterol, mg/dL | 58.3 ± 16.0 |
| LDL cholesterol, mg/dL | 153.0 ± 42.1 |
| Systolic blood pressure, mm Hg | 132.0 ± 9.1 |
| Diastolic blood pressure, mm Hg | 80.0 ± 7.5 |
| Baseline hypertension statusa | |
| No hypertension | 120 (74) |
| Hypertension | 43 (26) |
| Uric acid, mg/dLb | 4.7 ± 1.2 |
| High sensivity C-reactive protein, mg/Lb | 3.2 ± 4.0 |
aDefined as baseline SBP ≥ 140 or DBP ≥ 90 mmHg
bOnly measured in 159 participants due to lost specimens